CONTRACT FOR CARE · RIGHTS, CONSENT & GOVERNMENT POWER
Our Legal Case
A patient’s need for medicine should not become the pressure used to obtain a criminal admission. Examine compulsory disclosures, penalties for silence, coerced rights waivers, and the circumstances behind the signature.
Use this state record to trace the legal requirement, then compare it with the terms an office adds. The full work explains the constitutional case, consent analysis, evidence needed, and protections to demand.
Apply the constitutional and consent review to this record
- Government responsibility: Which law, binding rule, agency instruction, or public-provider policy requires the particular disclosure or consequence? Separate it from provider-added terms.
- Potential criminal admission: Identify the exact spoken answer, written history, certification, or explanation and the real criminal risk it creates.
- Penalty for silence: Record what happens if the patient invokes the privilege or refuses a rights waiver, including denial, discharge, or interruption of treatment.
- Consent and pressure: Preserve the circumstances of signing, severity of pain, accessible alternatives, and whether the patient could honestly accept the prospective obligations.
- Criminal-use protection: Identify legally sufficient immunity and limits on use of both the answer and evidence derived from it. A privacy assurance is a separate protection.
Read the precedents, evidence framework, clause review, and remedies and reform demands. The work develops a proposed constitutional challenge; applying it to a particular condition requires its facts and legal authority.
Indiana · Published conditions
Read the provision and its consequence together
30 selected comparisons across five organizations. Each agreement has six selected rows. Summit’s agreement-text gap is listed separately. Indiana Health Group is a behavioral-health comparator, not a verified opioid pain clinic.
Indiana requires a signed treatment agreement within defined chronic-opioid prescribing circumstances. The rule supplies minimum subjects and calls for the prescriber’s policies. That does not make every clinic deadline, waiver or termination decision a state-mandated clause.
Baseline key
IN-A: agreement subjects · IN-T: testing · IN-V / IN-P: visits and participation · IN-D: dose review. Each reference is to the physician chronic-pain rule, within its defined scope.
Center for Pain Management — American Pain Consortium
Public agreement linked — current office use unconfirmed
Currently linked two-page agreement; footer NP Packet 8-21-2019 PT2. Document / policy source · Current practice source
The forms page links this version for returning patients. Use by each office or patient group needs confirmation. Affiliated surgery centers are not counted as prescribing offices.
| Selected term / source | Baseline reference | Document provision | Stated consequence / limit |
|---|---|---|---|
| Outside procedures · p. 1, §10 | IN-P: treatment expectations; no specified transfer condition. | Prior consent for outside procedures; transferring interventional care carries an expectation the receiving clinician assumes prescribing. | General breach clause may end medication and relationship. |
| Other treatment · p. 1, §12 | IN-P: assess progress and treatment participation. | Follow the clinician’s program, which may include procedures. | Nonparticipation may lead to opioid withdrawal from the plan. |
| Dose changes · p. 1, §13 | IN-D: review above 60 MME; not a fixed ceiling. | Dose may fall with changing regulatory/consensus views, despite perceived poorer pain control. | Possible dose reduction. |
| Confidentiality · p. 2 | IN-A: no specified law-enforcement waiver. | Prescription-privacy waiver authorizes cooperation with law enforcement. | Potential disclosure for diversion investigations. |
| Refill visits · p. 2 | IN-V: four-month stable / two-month changing-plan minimums. | Monthly in-person scheduled visits; no emergency or after-hours refills. | Refills limited to stated process. |
| Loss/theft · p. 1, §11 | IN-A: safe-storage discussion; no specified replacement ban. | Patient must safeguard medication. | Time without medication and possible reassessment. |
Office records: Brownsburg · Carmel · Indianapolis · Evansville · Fishers · Greenwood · Indianapolis · Jasper · Kokomo · Lafayette · Munster
Indiana Neurology & Pain Center
Public agreement linked — current office use unconfirmed
Currently linked 16-page packet; opioid contract on PDF pages 12–13; 2024 upload path. Document / policy source · Current practice source
Branch adoption is unconfirmed. Treatment participation does not by itself establish a requirement to purchase services from an affiliated provider.
| Selected term / source | Baseline reference | Document provision | Stated consequence / limit |
|---|---|---|---|
| Program participation · p. 12, §1 | IN-P: set expectations for other treatment. | Participation in all aspects of the pain program. | Refusal does not oblige continued opioid prescribing. |
| Visit frequency · p. 12, §2 | IN-V: four-month stable / two-month changing-plan minimums. | Visits every four weeks; provider-approved exceptions. | General noncompliance clause may end opioids or care. |
| Pill-count deadline · p. 12, §12 | IN-A: random-count permission; no same-day deadline specified. | Attend the day called, with original bottles. | Refusal results in termination. |
| Law-enforcement cooperation · p. 13, §13 | IN-A: no specified law-enforcement authorization. | Authorizes clinic/pharmacy cooperation in diversion investigations. | Potential disclosure to enforcement agencies. |
| Alcohol · p. 13, §21 | IN-A: disclose alcohol use; no automatic-discharge requirement. | Alcohol included among contract violations. | Possible termination. |
| Pregnancy · p. 13, §23 | IN-A: pregnancy-risk counseling; no automatic-stop requirement. | Notify clinician of pregnancy. | Form states narcotics will be discontinued. |
Office records: Indianapolis · Indianapolis
Pain Control Associates
Public agreement linked — current office use unconfirmed
Currently linked one-page Narcotic Agreement; 2023 upload path. Document / policy source · Current practice source
Testing facility choice is expressly preserved. The Illinois office and separately listed surgical sites are excluded from this Indiana office count.
| Selected term / source | Baseline reference | Document provision | Stated consequence / limit |
|---|---|---|---|
| Testing deadline and choice · p. 1 | IN-T: medically necessary testing; no 48-hour deadline specified. | Urine/blood screening within 48 hours; patient may choose facility. | Refusal or noncompletion ends narcotic management. |
| Replacement · p. 1 | IN-A: safe-storage discussion; no police-report condition specified. | Police-report copy required for lost/stolen replacement consideration. | No replacement without report. |
| Medication bottles · p. 1 | IN-A: random-count permission; not every-visit bottles. | Bring bottles and remaining medicine to every visit. | May need to return with bottles before prescription. |
| Alcohol · p. 1 | IN-A: disclosure is required. | Alcohol prohibited with controlled substances. | General breach clause ends prescribing relationship. |
| Driving · p. 1 | IN-A: no categorical driving clause specified. | Driving/heavy machinery prohibited while taking controlled substances. | General breach provision applies. |
| Pharmacy · p. 1 | IN-A: no single-pharmacy clause specified. | One pharmacy; notify changes. | General breach provision applies. |
Office records: Schererville
Rehabilitation Associates of Indiana
Public agreement linked — current office use unconfirmed
Currently linked 11-page packet; agreement on PDF pages 5–6, revised August 20, 2021. Document / policy source · Current practice source · Existing SOV agreement record
The previously published SOV agreement record remains available. Pharmacy availability exceptions and approved primary-care prescribing arrangements matter when applying the form.
| Selected term / source | Baseline reference | Document provision | Stated consequence / limit |
|---|---|---|---|
| Other prescribers · p. 5 | IN-A: disclose controlled substances; not an absolute outside-care ban. | No seeking outside pain medicine; approved primary-care arrangements addressed separately. | Unapproved outside prescribing leads to termination. |
| Alcohol · p. 5 | IN-A: disclosure is required. | No alcohol with prescription pain medication. | Termination stated. |
| Monitoring deadline · p. 5 | IN-A / IN-T: count permission and medically necessary testing. | Comply within allotted time; no fixed duration printed. | Otherwise released from practice. |
| Loss/theft · p. 5 | IN-A: safe-storage discussion; no replacement ban specified. | Safeguard medication. | A period without prescribed medication. |
| Pharmacy · p. 6 | IN-A: no single-pharmacy clause specified. | Designated pharmacy; acknowledges changes may be necessary for availability. | No separate penalty stated for necessary changes. |
| Confidentiality · p. 6 | IN-A: no specified law-enforcement waiver. | Prescription-privacy waiver permits pharmacy and law-enforcement cooperation. | Potential disclosure for diversion investigations. |
Office records: Indianapolis · Bloomington
Indiana Health Group
Behavioral-health agreement comparator
Currently linked two-page Controlled Substance Agreement; 2021 upload path. Document / policy source · Current practice source · Existing SOV agreement record
Behavioral-health comparator, not a verified opioid pain-management office. This broad controlled-substance form is not automatically governed by the chronic-pain opioid rule.
| Selected term / source | Baseline reference | Document provision | Stated consequence / limit |
|---|---|---|---|
| Routine screening · p. 1 | IN-T applies only within chronic-pain opioid scope. | Random urine/saliva screens; absent prescribed drug or refusal is a violation. | Possible end of controlled prescribing or care. |
| Pill counts · p. 1 | IN-A: random-count permission in covered pain care. | Bring controlled-substance bottles when requested. | Failure is an agreement violation. |
| Lost/damaged medication · p. 1 | IN-A: no blanket replacement ban specified. | No replacement for loss, theft or other listed mishaps. | Replacement denied. |
| Early refills · p. 1 | IN-A: prescribing policies required, exact timing not fixed. | No early refills. | Patient may be without medication. |
| Refill request · p. 2 | IN-A: no three-day/personal-call rule specified. | Patient calls three days ahead; pharmacy requests not accepted. | Requests must follow clinic process. |
| Missed appointments · p. 2 | IN-V only governs covered chronic-pain opioid treatment. | Missed visit may lower/stop medicine; repeated misses/cancellations may end care. | Possible prescribing change or termination. |
Office records: Carmel
Summit Pain Management
Agreement text needed — intake packet available
Currently linked nine-page new-patient packet; 2022 revision markings. Document / policy source · Current practice source
Reviewed packet covers intake, financial consent, privacy and history. A complete opioid agreement was not identified; no missing contract clauses are inferred.
Agreement text needed. No contract terms inferred.
Office records: Fort Wayne · Fort Wayne · Auburn · Kendallville · Warsaw · Marion · Wabash · Huntington · Bluffton
Reviewed October 13, 2026. A shared form does not establish adoption at each branch. Actual enforcement, new-patient availability and prescribing decisions have not been verified.